Optimization of Syndromic Respiratory Panel Testing During a ‘Twin-Demic’ Respiratory Season: Inclusion of SARS-CoV-2
Presented by: Jose Alexander, MD., D(ABMM) FCCM, BCMAS SM, MB(ASCP)
Molecular diagnostics for respiratory infections play a key role in global health, testing for influenza during the winter, and multiple viruses and bacteria that cause influenza-like-illness year-round.
Sample-to-answer respiratory panels aid laboratories and clinicians in delivering rapid, clinically actionable results for patient management, therapeutic prescribing, cohorting and/or hospital admission decision-making.
Though many SARS-CoV-2 tests are available, the need to detect other viruses and bacteria is more important than ever. The ePlex® Respiratory Pathogen Panel 2 detects more than 20 respiratory pathogens, including SARS-CoV-2, to optimize efficiency during the 2020/2021 respiratory season while delivering rapid, quality results for critical patient care.
Dr. Jose Alexander obtained his MD degree from the Central University of Venezuela and trained as a Medical & Public Health Microbiologist.
He is board certified by the American Board of Medical Microbiology (ABMM) and a Fellow from the Canadian College of Microbiology; also, he is certified as Specialist in Microbiology and Molecular Biologist by the American Society for Clinical Pathologists (ASCP) and a Board Certified Medical Affairs Specialist by the American Council for Medical Affairs (ACMA).
He currently is the Clinical & Technical Director of the Microbiology, Virology and Immunology Laboratories at AdventHealth Orlando.
Dr. Alexander is passionate with the integration of resistant markers and MIC for a better use of antimicrobial and precision medicine.
Register Below for Instant Access to This Webinar